Delivery Order SPE2DB22D9353-SPE2DB25FX2BK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,783.32 to DMS Pharmaceutical Group Inc. for Daunorubicin 20 mg/4 ml vials on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a pharmaceutical supply requirement for an oncology medication used in cancer treatment protocols. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its capabilities as a...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,632.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on July 23, 2025, represents one of numerous task orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,122.99 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a discrete pharmaceutical supply delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The award carries no set-aside...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain program, awarded a delivery order valued at $92,440.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,347.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on September 28, 2025, falls under the DLA's larger Pharmaceutical Prime Vendor Fleet program and represents a continuation of the agency's pharmaceutical supply chain operations. The contract carries no set-aside designation, reflecting DMS...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $35,381.35 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies. The contract has a completion date of January 31, 2024 and is not designated as a set-aside. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that holds a broader indefinite delivery contract valued up to $4,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $23,866.20 by the Defense Logistics Agency's Medical Supply Chain division on July 30, 2025. This delivery order, with an ultimate completion date of July 31, 2025, represents a single issuance under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a continuation of the company's substantial role as a prime vendor within the DLA's pharmaceutical supply network. The award carries no set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $37,693.80 by the Defense Logistics Agency's Medical Supply Chain division on August 13, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and represents performance at the contractor's Park Ridge location. The award leverages DMS Pharmaceutical Group's position...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $22,707.56 by the Defense Logistics Agency's Medical Supply Chain division on August 28, 2025, with an ultimate completion date of September 4, 2025. This delivery order was issued without a set-aside designation and represents pharmaceutical products to be delivered to the Park Ridge, Illinois location. The award is issued...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2BKDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,566.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Daunorubicin 20 mg/4 ml vials. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a standard pharmaceutical supply delivery with no set-aside designation applied. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and deliver the oncology medication to support the federal healthcare supply chain. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. As a prominent federal pharmaceutical supplier, DMS Pharmaceutical Group has established itself as a critical distributor providing branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The company's consistent performance on similar delivery orders for specialized pharmaceutical products, including oncology treatments and other critical medications, positions it as a key vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/7/25 |